Rankings and comparisons

Published scorecards for FDA-approved medicines, side-by-side label comparisons, and telehealth reviews. A higher score is an editorial reading of public evidence and access. It is not a prescription.

What belongs here

Ranked lists of FDA-approved GLP-1 and dual GIP/GLP-1 medicines.
Head-to-head comparisons of labels, pivotal trials, and published price paths.
Reviews of telehealth programs that can name the product and the pharmacy.

Unapproved compounded products, research peptides, and overseas gray-market sellers are excluded on purpose. The weights are on the methodology page.

Nothing in this index is public yet.

Rankings and comparisons are type-checked in the repo while they are drafts, and they are left out of the build. This page will list them after an editor sets draft to false.

See how a score is built